Total Neoadjuvant Therapy for Operable Pancreatic Cancer-Reference-Cited by-同舟云学术

Total Neoadjuvant Therapy for Operable Pancreatic Cancer

Published:2020-09-30 Issue:4 Volume:28 Page:2246-2256
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kim Rebecca Y.,Christians Kathleen K.,Aldakkak Mohammed,Clarke Callisia N.,George Ben,Kamgar Mandana,Khan Abdul H.,Kulkarni Naveen,Hall William A.,Erickson Beth A.,Evans Douglas B.,Tsai Susan

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-020-09149-3.pdf

Reference41 articles.

1. Christians KK, Tsai S, Mahmoud A, et al. Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm? Oncologist. 2014;19(3):266–274. https://doi.org/10.1634/theoncologist.2013-0273

2. Christians KK, Heimler JW, George B, et al. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Surg (United States). 2016;159(3):893–900. https://doi.org/10.1016/j.surg.2015.09.018

3. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335–1339. https://doi.org/10.1001/archsurg.1992.01420110083017

4. Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148(1-2):349–361. https://doi.org/10.1016/j.cell.2011.11.025

5. Murphy JE, Wo JY, Ryan DP, et al. Total neoadjuvant therapy with FOLFIRINOX in combination with Losartan followed by Chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial. JAMA Oncol. 2019;5(7):1020–1027. https://doi.org/10.1001/jamaoncol.2019.0892

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX;Journal of Clinical Medicine;2024-09-02

2. Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes;Practical Radiation Oncology;2024-09

3. Total Neoadjuvant Therapy for Pancreatic Cancer—What Is Totality?;JAMA Surgery;2024-07-01

4. Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?;Cancers;2024-06-30

5. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy;JAMA Network Open;2024-06-18